NEW YORK (GenomeWeb News) – Oligonucleotide synthesis company Integrated DNA Technologies announced today that it has purchased VH Bio's oligonucleotide business.

Under the agreement, IDT will serve VH Bio's oligonucleotide customers from IDT's European synthesis facility, which opened in Leuven, Belgium, this past September. As such, IDT plans to provide current VH Bio customers with a broader product range of quality-controlled oligonucleotides that are available for next-day delivery.
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.